Research Topics
| David CulverSummaryAffiliation: Centers for Disease Control and Prevention Country: USA Publications
| Collaborators
|
Detail Information
Publications
Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural UgandaJonathan Mermin
CDC Uganda, Global AIDS Program, National Center for HIV, STD and TB Prevention, National Center for Infectious Diseases Centers for Disease Control and Prevention, Atlanta, GA, USA
Lancet 364:1428-34. 2004..We assessed the effect of such prophylaxis on morbidity, mortality, CD4-cell count, and viral load among people with HIV infection living in rural Uganda, an area with high rates of bacterial resistance to co-trimoxazole...- Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family membersJonathan Mermin
CDC Uganda, Global AIDS Program, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention CDC, and Uganda Virus Research Institute, Entebbe, Uganda
AIDS 19:1035-42. 2005..The effect of cotrimoxazole prophylaxis taken by persons with HIV on community health and antimicrobial resistance is unknown... - Developing an evidence-based, preventive care package for persons with HIV in AfricaJonathan Mermin
CDC Uganda, Global AIDS Program, National Center for HIV, STD and TB Prevention Centers for Disease Control and Prevention, Entebbe, Uganda
Trop Med Int Health 10:961-70. 2005..The provision of a basic care package could be an important step toward reducing health care disparities and gaining more control of the global HIV/AIDS epidemic... - Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort studyJonathan Mermin
CDC Uganda, Global AIDS Program, National Center for HIV, STD and TB Prevention, Centers for Disease Control and Prevention CDC, Entebbe, Uganda
Lancet 367:1256-61. 2006.... - Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort studyJonathan Mermin
Centers for Disease Control and Prevention Uganda, Global AIDS Program, National Center for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Prevention, Centers for Disease Control and Prevention, Entebbe, Uganda
Lancet 371:752-9. 2008..We therefore assessed the effect of a home-based ART programme in Uganda on mortality, hospital admissions, and orphanhood in people with HIV-1 and their household members... - Risk factors for recent HIV infection in UgandaJonathan Mermin
Global AIDS Program, National Center for HIV, Viral Hepatitis, STD and TB Prevention, Centers for Disease Control and Prevention Uganda, Entebbe, Uganda
JAMA 300:540-9. 2008..Studies of factors associated with acquiring human immunodeficiency virus (HIV) are often based on prevalence data that might not reflect recent infections... - Does using a laparoscopic approach to cholecystectomy decrease the risk of surgical site infection?Chesley Richards
Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
Ann Surg 237:358-62. 2003..To assess the impact of laparoscopy on surgical site infections (SSIs) following cholecystectomy in a large population of patients... - Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster doseAnthony E Fiore
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Mailstop G37, 1600 Clifton Road, Atlanta, GA 30333, USA
Pediatr Infect Dis J 22:354-9. 2003..Infants with passively transferred maternal antibody (PMA) to hepatitis A virus (HAV) have lower concentrations of antibody to HAV (anti-HAV) after vaccination. We examined the effect of PMA on persistence of anti-HAV and on immune memory...